子宮頸癌疫苗引發多發性硬化症
#國一女生十二月初將公費施打子宮頸癌疫苗
#葛蘭素藥廠的葛喜疫苗Gardasil
#弊多於利呼籲停止注射這類的疫苗
#
才能真正保護小女生現在與日後的健康
全台國一女生，原定今年十一月，要統一施打人類乳突病毒疫苗(HPV疫苗)，目的在預防子宮頸癌，一般稱為子宮頸癌疫苗。後來因故(很可能是各方雜音抗議)延到十二月施打。期間，監察院認為(衛福不)沒有審慎評估啟動調查，眼看時間快到，沒有再聽到後續進展。
這是篇具體的文章，指出在澳洲因為施打HPV疫苗(人類乳突病毒)，引發多發性硬化症的兩個案例。澳洲不只少女要施打，男生也要。所以患者一位是男生，一位是女生。多發性硬化症是一種衰弱性疾病，影響到中樞神經系統，在大腦，脊髓和視神經的神經脈衝產生干擾。
世界衛生組織的不良通報，資料庫就有36,915個案例，多在神經病變，還有自體免疫疾病。
這種疫苗目前最有名是葛蘭素藥廠的葛喜，英文叫Gardasil。裡面的主要成分是『鋁』，是一種神經毒素。施打後，會遊走到大腦停留累積。它能激起免疫系統的作用，超過自然反應的104倍。
文中並提到以澳洲為例，這類疫苗的不良反應率是2.5~3%，代表施打的每十萬人當中就有2300例不良反應；而子宮頸癌致死率是每十萬人7例。可以看出多麼地不合比例嗎？失去任何說服性的理由需要施打。
世界衛生組織的不良通報，就有36,915個案例，多在神經病變，還有自體免疫疾病。
這種疫苗目前最有名是葛蘭素藥廠的葛喜，英文叫Gardasil。裡面主要的成分是『鋁』，是一種神經毒素。施打後，會遊走到大腦停留累積。它能激起免疫系統的作用，超過自然反應的104倍。
文中並提到以澳洲為例，這類疫苗的不良反應率是2.5~3%，代表施打的每十萬人當中就有2300例不良反應；而子宮頸癌致死率是每十萬人7例。可以看出多麼地不合比例嗎？完全看不出任何需要施打的理由。
葛蘭素藥廠並將葛喜再升級。從本來的二價/四價，提高到九價。以澳洲的例子是施打九價。九價中，鋁的劑量是500mcg，需打兩劑，也就是進到人體的劑量是1000mcg。
越來越多人投入這些研究，結果會越來越具體。無法再像以前丟一句，『你不知道這些併發症是否跟疫苗有關』。更積極面應該是呼籲這些藥廠，停止研發製造這類無異於人類的疫苗。(因為它跟公共衛生一點關係都沒有)不僅如此，還會為將來要孕育生命的女性，帶來很多無法逆料的健康威脅。
補充資料
疫苗中除了鋁很驚世以外，另一個成分，Polysorbate 80 的化學乳化劑也不遑多讓，會壓抑免疫系統(讓你天生的保全動彈不得)，繞過血液大腦的屏障，造成日後的不孕等諸多症狀。這東西從未實驗證明可以打入人體，具備安全性。等於打開一道門，讓其他物質也溜進來。(把保全綁住讓其他同夥一道進來)
國外施打子宮頸癌疫苗，引發多發性硬化症的關聯案例
https://americanhealthnews.info/its-official-teens-diagnosed-with-ms-after-gardasil-vaccines/?fbclid=IwAR3gJlonHic2IVHInhUcM519ivZGjmEQ8jjwy3lhrpt26jF3GjbVkHlpe-4
監察院要求啟動疫苗調查
https://www.cy.gov.tw/sp.asp…
「國一女」可公費施打子宮頸癌疫苗
https://health.ettoday.net/news/1249741
補充資料:
疫苗中除了鋁很驚世以外，另一個成分，Polysorbate 80 的化學乳化劑也不遑多讓，會壓抑免疫系統(讓你天生的保全動彈不得)，繞過血液大腦的屏障，造成日後的不孕等諸多症狀。這東西從未實驗證明可以打入人體，具備安全性。等於打開一道門，讓其他物質也溜進來。(把保全綁住讓其他同夥一道進來)
是正式案例，青少年施打葛喜疫苗後，
被診斷出有多發性硬化症
2015年，一項斯堪地維亞的研究發現，400萬女性中80萬人曾接受HPV疫苗(人類乳突病毒疫苗)接種，多發性硬化症或脫髓鞘病的風險並沒有增加。
但最近在聖地牙哥所舉辦的一場論壇上，研究人員提出兩個多發性硬化症的案例（MS），在接種子宮頸癌疫苗的少女身上發病的。
葉虎所提出的報告，指出兩名青少年在接種HPV疫苗一到兩個禮拜後，爆發多發性硬化症。
一名十四歲的少年在接受第三劑葛喜疫苗注射後兩個禮拜，左眼眶痛，以及左眼視力模糊。他被診斷出患有左側視神經炎，症狀2個月後再次出現。
一名17歲少女，接受第一劑葛喜(Gardasil)後兩周，開始出現右眼視力模糊。 核磁共振造影（MRI）觀察到右額葉增強病變。也被診斷出右視神經炎，沒有再施打進一步劑量的葛喜。停打一周後，除了右眼視力模糊外，下肢也出現間歇性的麻痺和虛弱。再做一次核磁共振造影，出現左側枕葉有病變增強的現象。
很高興看到這類的研究，揭開未來更多的研究，開啟對話的信號，看出跟人類乳突病毒有關的問題，發生在數千起接種後不良的反應與數百名死亡的案例中。
根據疾病管制局/疫苗不良事件通報系統，接種葛喜(Gardasil)疫苗後回報53例多發性硬化症，以及新的葛喜九價疫苗則有2例回報。這都只是冰山的一角，
因為很少案例真正回報。大多數的人不曉得要去哪裡或如何回報，以便註記不良記錄。還有，就是不知道如何判斷這個併發症，是跟疫苗有關，還是巧合。
加拿大研究人員露西亞與克莉斯多福指出，沒有確切的測試能確定不良反應是跟疫苗有關。他們討論到注射疫苗後的各種回報系統，到診斷出有腦血管炎（大腦的血管發炎），但認為沒有關係。腦血管炎的症狀包括：
•密集持續的偏頭痛
•昏厥
•發作
•發抖和耳鳴
•肌肉疼痛
•運動異常
•精神病症狀和認知缺陷
多發性硬化症的症狀可能跟其他病類似，如急性腦脊髓炎（ADEM），包括協調和語言的問題，視力困難，疲勞和虛弱。
在我的書『葛喜：快速有問題(Gardasil：Fast-Tracked and Flawed)』中，我引述克莉絲鄧的經歷，她是一名26歲的澳洲女性，接受第二劑葛喜的注射後，發現她的健康開始以毀滅性的方式崩解。
開始是短暫失去視力和行動問題，讓她沒辦法跑，跳，跳舞或穿著她心愛的高跟鞋。然後不能寫字：「一下寫字寫不動了，」她喊道。最糟的是當克里斯鄧講話變得含糊不清時，「他們以為我中風了。」
克莉絲鄧最初被診斷為多發性硬化症，並且用皮質類固醇治療失敗。進一步的檢驗發現她患有急性腦脊髓炎（ADEM），是一種免疫媒介的發炎性脫髓鞘病，主要影響大腦和脊髓的白質。
多發性硬化症是一種衰弱性疾病，影響中樞神經系統，在大腦，脊髓和視神經的神經脈衝產生干擾。診斷有多發性硬化症的平均年齡是30歲，但近年來，在澳洲被診斷患有這種疾病的年輕女性急劇增加。以前是男性與女性都會受到影響，但現在可能受到影響的女性是其三倍。
最近，我遇到一位年輕女子，對於診斷出多發性硬化症，她終於感到放心。因為沒有人告訴為什麼她會那麼不舒服。她的症狀從13歲就開始，包括頭痛，腿部無知覺的缺陷，以及疲勞讓她必須常向學校請病假。
當我聽到她的故事，就在想她是否受害於疫苗損傷。神經功能障礙是葛喜最常見的不良反應之一。她的症狀從13歲開始，正是少女在學校接種葛喜的年紀。
在所有這些中，我不禁在想，有多少女孩和男孩被診斷出有多發性硬化症、以及其他神經症狀、還有自體免疫疾病。而不單單是疫苗傷害。有時，最終還是會做出正確的診斷，就像娜歐蜜一樣，這位28歲的墨爾本女性，在接種葛喜疫苗後，患有自身免疫和神經系統的疾病。她最初被診斷患有多發性硬化症，但後來被診斷為患有對疫苗的神經性反應。
世界衛生組織的不良反應通報，資料庫有36,915個案例，接種葛喜後神經系統的失調。每一劑葛喜含有225微克的鋁，一種神經毒素，用來刺激對疫苗的免疫反應的佐劑。當克里斯鄧做了頭髮的礦物分析時，顯示出她體內含有高含量的鋁。
一旦在人體內，注射的鋁就會遷移累積在大腦。基爾大學的科學家最近發現疫苗佐劑中的鋁會從注射點傳播到大腦。
鋁的毒性潛力很強。研究顯示，注射的鋁佐劑會轉移到大腦，持續存在。
這種研究必須繼續，並引起當權者注意，他們持續在開發越來越多的疫苗，這些疫苗通常含有鋁佐劑，會引起免疫反應。
隨著新學年的開始，澳洲青少年將接種最新的九價葛喜疫苗，裡面的鋁佐劑含量，比過去的四價更高。打一次九價的葛喜疫苗，是500微克已知的神經毒素的劑量。女孩和男孩要接種兩次疫苗，代表打進年輕體內的鋁佐劑總量達1000mcg。
葛喜和葛喜九價，含有（AAHS），是鋁的新形式，會使免疫系統的大力地被刺激，勝過自然產生的104倍。
這些不良反應可以被避免，HPV疫苗接種計劃必須停止。我們的青少年不需要HPV疫苗來預防子宮頸癌。 自1991年，澳洲全國子宮頸癌普查有始以來，子宮頸癌死亡人數減少了一半。西方國家沒有這種流行病。2014年，澳洲有223個子宮頸癌死亡案例，大多數是老年婦女。
但我們卻為每個青少年準備了這種疫苗。
在『FDA批准的葛喜九價：瀆職或愚蠢』中，諾瑪查看葛喜九價的說明書，她發現，葛喜九價在測試過程中，嚴重不良反應率是2.3-2.5％。代表每10萬個施打葛喜疫苗的人當中，會有2,300例嚴重不良反應，而美國子宮頸癌發病率是每10萬名女性當中7例。這真得是精神錯亂了！
期待有更多這方面的研究，就是找出HPV疫苗與神經傷害和自體免疫疾病的關聯。讓真相公諸於世！
https://americanhealthnews.info/its-official-teens-diagnosed-with-ms-after-gardasil-vaccines/?fbclid=IwAR1C1hVleZz4ZchUgC22gvstSqmb71yE42uhar-HMymhVcFMVGAjK8ALZBg
By Helen Lobato
It’s Official – Teens Diagnosed With MS After Gardasil Vaccines
In 2015, a Scandinavian study found no increased risk for Multiple Sclerosis or demyelinating disease among 4 million females, of whom 800,000 received the HPV vaccinatio.
But at a recent forum in San Diego, researchers presented two cases of multiple sclerosis (MS) that had developed in teenagers after receiving Gardasil, the human papillomavirus (HPV) vaccine.
The study author Ye Hu reported on 2 teens who experienced MS symptoms 1 to 2 weeks after receiving the vaccination.
A 14-year-old male started to experience left retro-orbital pain and blurred vision in the left eye 2 weeks after receiving his third dose of Gardasil. He was diagnosed with left optic neuritis and reported a second occurrence 2 months after his initial symptoms.
A 17-year-old female started to experience blurred vision in the right eye 2 weeks after receiving her first dose of Gardasil. A right frontal enhancing lesion was seen on brain magnetic resonance imaging (MRI). She was diagnosed with right optic neuritis and did not receive further doses of Gardasil. One week after discharge, she experienced intermittent numbness and weakness in her lower extremities in addition to blurred vision in her right eye. A repeat brain MRI revealed a new left parieto-occipital enhancing lesion.
It is pleasing to read of this research, which is the start of much more to come and signals an opening up of a conversation that acknowledges the problems associated with the HPV vaccines manifesting in thousands of adverse events and hundreds of deaths occurring after the vaccination.
According to VAERS, the CDC’s vaccine adverse event reporting system, there have been 53 cases of multiple sclerosis reported after vaccination with Gardasil and two following the new HPV vaccine Gardasil 9. This is the tip of the iceberg as very few adverse events are reported with most people ignorant of where or how they are to go about the process of having their adverse health event recorded. Then there’s the problem of determining if symptoms of an adverse event are causally linked to vaccines or a coincidence.
Canadian researchers, Lucija Tomljenovic and Christopher A Shaw, note that there are no conclusive tests available to determine whether adverse events are causally linked to vaccinations. They discuss the fact that many of the symptoms reported to the various reporting systems following HPV vaccination point to a diagnosis of cerebral vasculitis (inflammation of blood vessels in the brain) but are not recognized as such. Symptoms of cerebral vasculitis include:
•intense persistent migraines
•syncope
•seizures
•tremors and tingling
•myalgia
•locomotor abnormalities
•psychotic symptoms and cognitive deficits
The symptoms of multiple sclerosis can also be similar to those of other diseases such as acute disseminated encephalomyelitis (ADEM) and include problems with coordination and speech, sight difficulties, fatigue and weakness.
In my book Gardasil: Fast-Tracked and Flawed I relate the experience of Kristin Clulow, a 26-year-old Australian woman who after her second shot of Gardasil found her health beginning to unravel in a devastating way.
It started with a temporary loss of vision and mobility problems that made it impossible for her to run, jump, dance or wear her beloved heels. Then her handwriting failed her: “Handwriting just doesn’t suddenly go,” she cried. Worse was to come when Kristin’s speech became slurred: “They thought I’d had a stroke.”
Kristin was initially given the diagnosis of multiple sclerosis and treated unsuccessfully with corticosteroids. Further tests revealed that she was suffering from acute disseminated encephalomyelitis (ADEM), an immune-mediated inflammatory demyelinating condition that predominately affects the white matter of the brain and spinal cord
Multiple sclerosis is a debilitating disease affecting the central nervous system with interference occurring in nerve impulses within the brain, spinal cord and optic nerves. The average age for a diagnosis of multiple sclerosis is 30, but in recent years the number of younger women diagnosed with the disease in Australia has risen dramatically. It used to affect men and women equally but now women are three times more likely to be affected.
Recently, I came across a young woman who was relieved to be diagnosed with MS because no-one had been able to tell her why she was unwell. Her symptoms began when she was 13 and consisted of headaches, sensory deficit affecting her leg, and fatigue resulting in her missing a lot of school.
I wondered as I listened to her story if she might be suffering a vaccine injury. Neurological dysfunction is one of the very common adverse events of the Gardasil vaccine. Her symptoms started at 13, the age that Gardasil is given to young teens as part of the school vaccination program.
In all of this, I have to wonder just how many girls and boys are diagnosed with MS and other neurological conditions and autoimmune diseases rather than with a vaccine injury. Sometimes the correct diagnosis is eventually made as it was in the case of Naomi Snell, a 28-year-old Melbourne woman who suffered autoimmune and neurological problems following her Gardasil vaccination. Snell was initially diagnosed with multiple sclerosis but was later diagnosed as suffering a neurological response to the vaccine.
Vigibase, the World Health Organisation’s database of adverse events reports 36,915 nervous system disorders following Gardasil vaccination. But then each shot of Gardasil contains 225 mcgs of aluminium, a neurotoxin used as an adjuvent to stimulate a vaccine immune response. When Kristin Clulow had a mineral analysis of her hair done it showed that her body was high in aluminium.
Once in the body, injected aluminium can migrate and accumulate in the brain. Scientists at Keele University have recently discovered the way the aluminium in vaccine adjuvants travels from the site of injection to the brain.
The toxic potential of aluminum is high. This study has demonstrated that injecting alum adjuvants with vaccines results in transference to the brain, where it persists.
Such research must be continued and heeded by those in power who continue to prescribe an ever-increasing number of vaccines often laden with aluminium adjuvants needed to bring about an immune response.
As the new school year begins, Australian teenagers will be offered the latest HPV vaccine Gardasil 9 which contains even more of the aluminium adjuvant than the quadrivalent HPV vaccine Gardasil. One shot of Gardasil 9 has 500 micrograms of this known neurotoxin. Girls and boys will receive two shots of the vaccine, bringing the total amount of aluminium injected into their young bodies up to 1000mcg.
Gardasil and Gardasil 9 contain amorphous aluminium hydroxyphosphate sulphate (AAHS) a new form of aluminium which causes the immune system to become 104 times more powerfully stimulated than would occur naturally.
The adverse events in their many forms can be avoided. The HPV vaccination programs must be stopped. Our teenagers do not need HPV vaccines to prevent them from cervical cancer. Since the Australian National Cervical Screening Program began in 1991, the number of deaths from the cervical cancer have halved. There is no epidemic of the disease in western nations. In 2014, there were 223 deaths from cervical cancer in Australia and the deaths were mostly among elderly women.
And yet we have institutionalised this vaccine for every teenager.
In “FDA approved Gardasil 9: Malfeasance or Stupidity?,” Norma Erickson examined the Gardasil 9 package insert where she found that the rate of serious adverse events in the trials of Gardasil 9 was 2.3-2.5%. This means that for every 100,000 people who are given Gardasil 9, there will be 2,300 serious adverse events, and yet the cervical cancer rate in the U.S. is around 7 women per 100,000. This is insanity!
Expect to hear more research linking HPV vaccines to neurological events and autoimmune diseases. The truth will come out!
Source:https://www.collective-evolution.com